Dr. Eva Keilhauer works as business development manager at Coriolis Pharma, with a special focus on liquid formulation development projects. Eva studied Pharmaceutical Sciences at the LMU Munich, followed by a PhD at the Max-Planck-Institute of biochemistry, focusing on mass spectrometry-based proteomics. Eva joined Coriolis in 2017 as a scientist, supporting and leading various formulation development projects. Since 2022, Dr. Keilhauer is a member of the commercial team, where she continues to apply her knowledge in formulation development to help clients tackle their specific challenges.